That's really encouraging to hear — a year in and feeling better is worth celebrating! Mounjaro (tirzepatide) is a dual-incretin therapy, meaning it works on both GLP-1 and GIP receptors, which makes it slightly different from standard GLP-1 drugs. But the good news is there is some emerging evidence suggesting these Show Full Answer
That's really encouraging to hear — a year in and feeling better is worth celebrating! Mounjaro (tirzepatide) is a dual-incretin therapy, meaning it works on both GLP-1 and GIP receptors, which makes it slightly different from standard GLP-1 drugs. But the good news is there is some emerging evidence suggesting these medications may help people with lupus.
Here's what the current research points to:
- A small study found GLP-1 medications helped reduce BMI in people with lupus without triggering flares
- Some studies suggest GLP-1 drugs may have mild anti-inflammatory properties, which could benefit those with lupus
- There are potential cardiovascular and kidney-protective benefits, which is particularly relevant for people with lupus nephritis
- Weight loss from these medications may help reduce overall inflammation, potentially easing lupus symptoms That said, the research is still in early stages, and most studies have focused on weight loss rather than lupus specifically. More research is needed to fully understand the connection.
It's worth discussing your improvement with your rheumatologist, as your experience could help guide your ongoing treatment plan.
July 4
Join
Your Privacy Choices
